chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding
Clinical narrative: I have an IUD that has stopped my menstrual cycle for the last 3 years. When I received the Pfizer Covid booster I started spotting. First time in 3 years.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, COVID-19, Intensive care, Metabolic disorder
Clinical narrative: [Pfizer Covid Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): Received Pfizer booster 12/17, admitted 12/20 after being found down for unknown amount of time, severe metabolic disarray, NSTEMI, AKI, also COVID +. Req. ICU admission
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: [Pfizer Covid Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): Received Pfizer booster 12/17, admitted 12/20 after being found down for unknown amount of time, severe metabolic disarray, NSTEMI, AKI, also COVID +. Req. ICU admission
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Decreased appetite, Ear pain, Malaise
Clinical narrative: Maderna booster shot received 11/03/21 and I had severe muscle and joint pain all over my body. Felt very sick and leg pains made it difficult to even sit at table to eat. I started a barking cough the next day and have continued to do so to this day 12/29/21. I also coughed for weeks after my first maderna shot as well. I also on the fifth day after my booster shot started to have severe pain in my neck, popping and clicking and dagger sharp pains up the side of my neck up to my right ear. I could not turn my head right. On day 15 after my booster shot my joint in my back right below my neck swelled up. I iced it. I have had to see an orthopedic doctor for my chronic cough and neck. I am very discouraged to receive any future vaccine shots after this experience. How do I proceed if unable to feel safe to take shot and demands of mandates that may be given to people to live their lives in the public environment.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Muscle tightness, Myalgia, Neck pain, Pain
Clinical narrative: Maderna booster shot received 11/03/21 and I had severe muscle and joint pain all over my body. Felt very sick and leg pains made it difficult to even sit at table to eat. I started a barking cough the next day and have continued to do so to this day 12/29/21. I also coughed for weeks after my first maderna shot as well. I also on the fifth day after my booster shot started to have severe pain in my neck, popping and clicking and dagger sharp pains up the side of my neck up to my right ear. I could not turn my head right. On day 15 after my booster shot my joint in my back right below my neck swelled up. I iced it. I have had to see an orthopedic doctor for my chronic cough and neck. I am very discouraged to receive any future vaccine shots after this experience. How do I proceed if unable to feel safe to take shot and demands of mandates that may be given to people to live their lives in the public environment.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Spinal X-ray, Spinal pain, Swelling
Clinical narrative: Maderna booster shot received 11/03/21 and I had severe muscle and joint pain all over my body. Felt very sick and leg pains made it difficult to even sit at table to eat. I started a barking cough the next day and have continued to do so to this day 12/29/21. I also coughed for weeks after my first maderna shot as well. I also on the fifth day after my booster shot started to have severe pain in my neck, popping and clicking and dagger sharp pains up the side of my neck up to my right ear. I could not turn my head right. On day 15 after my booster shot my joint in my back right below my neck swelled up. I iced it. I have had to see an orthopedic doctor for my chronic cough and neck. I am very discouraged to receive any future vaccine shots after this experience. How do I proceed if unable to feel safe to take shot and demands of mandates that may be given to people to live their lives in the public environment.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Severe Vertigo, Lightheaded Pfizer Covid-19 Booster
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Herpes zoster, Incomplete course of vaccination, Pyrexia, Skin disorder
Clinical narrative: After first and only Modrerna shot, awful shingles fever worse than that terrible G.I. Issues. Like taboo due to folks mandated vac. Even my primary care cannot help. Skin issues and gastrointestinal issues won't go away. I am a long haul trucker and was very healthy. Through much research found rare but not alone with this. Like it is trying to get me. Modrerna cares less.
Age: 87.0
Sex: U
Vaccine: COVID19
Symptoms: Cerebral haemorrhage, Computerised tomogram head abnormal, Neurological symptom
Clinical narrative: [Moderna Covid Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): pt received moderna covid shot on 12/2/2021. presented to ED on 12/27/2021 with stroke-like symptoms. CT demonstrates LEFT temporal lobe intraparenchymal hemorrhage
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: [Moderna Covid Vaccine] use for COVID-19 under Emergency Use  Authorization (EUA): pt developed covid pneumonia after receiving moderna covid shot
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Severe Vertigo when I woke up in the morning of 12/26/2021, after administration of Pfizer COVID-19 booster on 12/24/2021.
Sex: F
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: Per hospital event reporting system "Gave Tdap instead of Influenza vaccine".
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Fatigue, Muscle tightness, Myalgia, Pain in extremity
Clinical narrative: I got the COVID-19 Booster shot on 10/28/2021. The symptoms occurred starting the next day. I had a sore and tight heart muscle. Every time I coughed or lifted something my heart muscle felt soreness. I was extremely exhausted and just felt tired all day and night. My arm hurt for 5-7 days. It took around 45 day mark. I stayed in contact with my doctor on occasion and she said everything would be fine and to just take ibuprofen or something similar.
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Vertigo, Vestibular disorder
Clinical narrative: Received Pfizer booster on 10/11/21 and have had vestibular/vertigo symptoms since then requiring constant treatment for nausea and management of symptoms as well as multiple medical appointments with primary care, physical therapy, neurology, ENT, A significant impairment to my quality of life.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Underdose
Clinical narrative: Describe Event, Problem, or Product Use Error: [Moderna COVID vaccine] use for COVID -19 under Emergency Use Authorization (EUA): Per hospital reporting system "pt advised me he needed to make his follow up for 2nd Moderna Vaccine. That triggered me to question his 1st vaccine he had just received. (we do not offer 1st of 2nd Moderna vaccine at our facility at this time, only Moderna booster) I looked at the order in his chart for future which did in fact say Moderna. I went and consulted with Nurse Lead and she checked and pt did in fact receive the "Moderna booster" but was treated as vaccine #1 in error. She consulted with precepto and it was determined that patient would receive another injection with the remaining portion of the booster to complete Moderna vaccine #1. Patient agreed and then was advised to get the 2nd Moderna at an outside vaccine location per our current guidelines.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERD AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREES C
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING 90 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BRING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREES C
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEBREE C
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN DEGREE X
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 C
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Reaction to previous exposure to any vaccine
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINSTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEE 2-8 DEGREE C
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAY STORAGE BETWEEN 2-8 DEGREE C
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Dose Administered After 30 Day Storage Between 2-8 Degree C
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEUBG STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Dose administered after 30 days storage between 2-8 degree C.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Dose administered after being storage for 30 days between 2-8 degree C.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMNISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER 30 DAYS STORAGE BETWEEN 2-8 DEGREE C
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN BETWEEN 2-8 DEGREE C
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING A STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: DOSE ADMINISTERED AFTER BEING STORAGE FOR 30 DAYS BETWEEN 2-8 DEGREE C
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blindness, Eye pain, Fatigue, Gait disturbance
Clinical narrative: Approximately 15 hours after injection, patient woke sweating. Went to get glass of water to kitchen and upon return he states he was unable to see and was walking into the walls. He knew he had to urinate but does not remember going. Called Mom who came into bedroom to find patient sitting on the side of bed and incontinent with a puddle of urine in doorway. He was able to tell her exact sequence of events. Had HA behind eyes but was able to see, aching in all joints-especially knees. Temperature was 99.0. Mom gave Tylenol 500mg at 5am. Patient had headache and fatigue for approx 36 hours post vaccine. 12/30/2021-Mom states all symptoms have resolved and son is his normal self.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Urinary incontinence
Clinical narrative: Approximately 15 hours after injection, patient woke sweating. Went to get glass of water to kitchen and upon return he states he was unable to see and was walking into the walls. He knew he had to urinate but does not remember going. Called Mom who came into bedroom to find patient sitting on the side of bed and incontinent with a puddle of urine in doorway. He was able to tell her exact sequence of events. Had HA behind eyes but was able to see, aching in all joints-especially knees. Temperature was 99.0. Mom gave Tylenol 500mg at 5am. Patient had headache and fatigue for approx 36 hours post vaccine. 12/30/2021-Mom states all symptoms have resolved and son is his normal self.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ataxia, Blood test, Confusional state, Dysarthria, Headache
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Lethargy, Lumbar puncture, Magnetic resonance imaging head
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute disseminated encephalomyelitis, Alanine aminotransferase increased, Anti-ganglioside antibody negative, Antineutrophil cytoplasmic antibody negative, Antinuclear antibody negative
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arrhythmia, Aspartate aminotransferase increased, Aspergillus test negative, Asthenia, Autonomic nervous system imbalance
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bickerstaff's encephalitis, Borrelia test, Brain stem syndrome, C-reactive protein increased, CSF culture negative
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: CSF glucose normal, CSF protein increased, CSF test normal, CSF white blood cell count increased, Cardiolipin antibody negative
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cauda equina syndrome, Cryptococcus test, Electromyogram abnormal, Encephalitis viral, Epstein-Barr virus test negative
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, HIV test negative, Headache, Herpes simplex test negative, Hypoaesthesia
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immunoglobulin therapy, Inflammation, Influenza like illness, Intensive care, Lumbar radiculopathy
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Meningism, Mental status changes, Muscular weakness
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Myelitis transverse, Noninfective encephalitis, Pyrexia, Red blood cell sedimentation rate increased
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory viral panel, Spinal stenosis, Treponema test negative, Urinary retention, Varicella virus test negative
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vasculitis, Vertebral foraminal stenosis, Viral test negative, West Nile virus test
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute disseminated encephalomyelitis, Bickerstaff's encephalitis, Blood test, Brain oedema, Encephalitis autoimmune
Clinical narrative: On April 4, I received the J&J vaccine  On April 18, I was admitted to the local Hospital ER with near-death swelling of my brain shutting down my body's ability to function After weeks of being in the hospital, I was diagnosed with autoimmune encephalitis Bickerstaff syndrome by the ICU neuro doctors at the HCF.  The week of May 16, an aggressive steroid plan was introduced, and my ability to physically function returned to an acceptable level for independence.  On May 21, I was transferred for the third time to (rehab hospital) On May 29, I was discharged from the Rehab hospital with no restrictions. On Jun 15, my neurologist (Dr.) indicated she thought my condition was related to the J&J vaccine. This was around the same time J&J and the CDC announced the connection to Guillain-Barré syndrome   On July 13, my neurologist refined my diagnosis to ADEM (Acute Disseminated Encephalomyelitis)/AIDP (Inflammatory DemyselinatingPolyradiculopathy aka Gillian-Barre Syndrome) On Nov 19, my neurologist indicated she thought my symptoms would have been gone On Dec 20, I reported that I had 10 noticeable symptomatic events since our last meeting on Nov 19. I inquired about how I compare to my cohort of 278 individuals.